Skip to main content

Important Information

While under normal circumstances members of the public are welcome to attend our Part A Governing Body meetings, Government social distancing requirements relating to the Covid19 pandemic constitute ‘special reasons’ to avoid face to face gatherings.

Until further notice, all Governing Body meetings will be held virtually by default. 

If you would like to view the Meeting proceedings in real time, please send a request by email to: We will then be able to send you the MS Teams link and associated guidance. At present, Meetings will not be recorded for viewing at a later stage.

It will not be possible for us to take public questions on the day. However, we are happy to address any public questions received electronically (in advance) at the beginning of the meeting.  Please note that we may need to defer public questions should the focus of the meeting need to be prioritised in relation to Covid-19.

Questions should be succinct and relevant to general health care commissioning: they should not raise personal or individual issues.  So we can reply as fully as possible, we ask that public questions are submitted on the Public Questions Form in advance of the meeting via e-mail to:

A response will be sent directly to the individual who raised the question and in due course may also be put on a Q & A section on this page to enable members of the public to view.  Part A agenda papers and Minutes will continue to be published under the relevant meeting date as normal.

The next Governing Body Meeting

Our next Governing Body Meeting will be held on Thursday, 26 May 2022 at 9.30 am via MS Teams. Papers will be published here five days in advance of the meeting. If you wish to submit a public question, please use the Public Questions Form and send via e-mail to by midday on Tuesday, 24 May 2022.

Papers for meetings since January 2020 are available under Previous Governing Body Meeting papers. Papers from meetings pre-January 2020 can be provided on request, please contact us for further information.